Neoplasia: An International Journal for Oncology Research (Jan 2006)

Ad-IRF-1 Induces Apoptosis in Esophageal Adenocarcinoma

  • Gregory A. Watson,
  • Pierre E. Queiroz de Oliveira,
  • Michael T. Stang,
  • Michaele J. Armstrong,
  • William E. Gooding,
  • Shih-Fan Kuan,
  • John H. Yim,
  • Steven J. Hughes

DOI
https://doi.org/10.1593/neo.05559
Journal volume & issue
Vol. 8, no. 1
pp. 31 – 37

Abstract

Read online

The nuclear transcription factor interferon regulatory factor-1 (IRF-1) is a putative tumor suppressor, but the expression and function of IRF-1 in esophageal adenocarcinoma (EA) remain unknown. We hypothesized that IRF-1 expression was reduced or lost in EA and that restoration of IRF-1 would result in the apoptosis of EA cells in vitro and the inhibition of tumor growth in vivo. Three EA cell lines were used to examine IRF-1 expression, IFN-γ responsiveness, and the effects of IRF-1 overexpression using a recombinant adenoviral vector (Ad-IRF-1). All three EA cell lines produced IRF-1 protein following IFN-γ stimulation, although IFN-γ did not induce cell death. In contrast, Ad-IRF-1 infection resulted in high levels of IRF-1 protein and triggered apoptosis in all three EA cell lines. Potential mechanisms for the differential response to IFN-γ versus Ad-IRF-1-such as modulation of c-Met or extracellular regulated kinase signaling, or altered expression of IRF-2, Fas, or survivin-were investigated, but none of these mechanisms can account for this observation. In vivo administration of IRF-1 in a murine model of EA modestly inhibited tumor growth, but did not lead to tumor regression. Strategies aimed at increasing or restoring IRF-1 expression may have therapeutic benefits in EA.

Keywords